Wesley Nuffer - Search Results

Year	Number of Results
2009	1
2012	2
2013	4
2014	3
2015	5
2016	2
2017	6
2018	3
2019	5
2020	2
2021	5
2022	5
2023	2
2024	1

1

GLP-1 receptor agonists: an updated review of head-to-head clinical studies.

Trujillo JM, Nuffer W, Smith BA. Trujillo JM, et al. Among authors: nuffer w. Ther Adv Endocrinol Metab. 2021 Mar 9;12:2042018821997320. doi: 10.1177/2042018821997320. eCollection 2021. Ther Adv Endocrinol Metab. 2021. PMID: 33767808 Free PMC article. Review.

2

Tirzepatide: A novel, first-in-class, dual GIP/GLP-1 receptor agonist.

Tall Bull S, Nuffer W, Trujillo JM. Tall Bull S, et al. Among authors: nuffer w. J Diabetes Complications. 2022 Dec;36(12):108332. doi: 10.1016/j.jdiacomp.2022.108332. Epub 2022 Oct 5. J Diabetes Complications. 2022. PMID: 36375235 Review.

3

A review of sotagliflozin for use in type 1 diabetes.

Nuffer W, Williams B, Trujillo JM. Nuffer W, et al. Ther Adv Endocrinol Metab. 2019 Nov 26;10:2042018819890527. doi: 10.1177/2042018819890527. eCollection 2019. Ther Adv Endocrinol Metab. 2019. PMID: 31807264 Free PMC article. Review.

4

Sweetly Improving Sugars? Reviewing Cinnamon's Effects on Blood Glucose.

Nuffer W, Tall Bull S, Bakhach H, Nuffer M. Nuffer W, et al. J Med Food. 2023 Jan;26(1):68-73. doi: 10.1089/jmf.2022.0073. Epub 2022 Oct 7. J Med Food. 2023. PMID: 36206028 Review.

5

Liraglutide: A New Option for the Treatment of Obesity.

Nuffer WA, Trujillo JM. Nuffer WA, et al. Pharmacotherapy. 2015 Oct;35(10):926-34. doi: 10.1002/phar.1639. Pharmacotherapy. 2015. PMID: 26497479 Review.

6

Cardiovascular Outcomes of New Medications for Type 2 Diabetes.

Trujillo JM, Wettergreen SA, Nuffer WA, Ellis SL, McDermott MT. Trujillo JM, et al. Among authors: nuffer wa. Diabetes Technol Ther. 2016 Dec;18(12):749-758. doi: 10.1089/dia.2016.0295. Epub 2016 Nov 11. Diabetes Technol Ther. 2016. PMID: 27835045 Review.

7

A Comparison of New Pharmacological Agents for the Treatment of Obesity.

Nuffer W, Trujillo JM, Megyeri J. Nuffer W, et al. Ann Pharmacother. 2016 May;50(5):376-88. doi: 10.1177/1060028016634351. Epub 2016 Feb 17. Ann Pharmacother. 2016. PMID: 26887340 Review.

8

A review of the new GLP-1 receptor agonist/basal insulin fixed-ratio combination products.

Nuffer W, Guesnier A, Trujillo JM. Nuffer W, et al. Ther Adv Endocrinol Metab. 2018 Mar;9(3):69-79. doi: 10.1177/2042018817752315. Epub 2018 Jan 19. Ther Adv Endocrinol Metab. 2018. PMID: 29492243 Free PMC article. Review.

9

GLP-1 receptor agonists: a review of head-to-head clinical studies.

Trujillo JM, Nuffer W, Ellis SL. Trujillo JM, et al. Among authors: nuffer w. Ther Adv Endocrinol Metab. 2015 Feb;6(1):19-28. doi: 10.1177/2042018814559725. Ther Adv Endocrinol Metab. 2015. PMID: 25678953 Free PMC article. Review.

10

Effect of an Advanced Pharmacy Practice Experience on Medication Therapy Management Services in a Centralized Retail Pharmacy Program.

Vande Griend JP, Rodgers M, Nuffer W. Vande Griend JP, et al. Among authors: nuffer w. J Manag Care Spec Pharm. 2017 May;23(5):561-565. doi: 10.18553/jmcp.2017.23.5.561. J Manag Care Spec Pharm. 2017. PMID: 28448777 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

43 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Results by year